13F reference period
Q3 2026
Security Snapshot
CORCEPT THERAPEUTICS INC - Common Stock (CORT) Institutional Ownership
CUSIP: 218352102
13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026
Institutions Reporting
311
Shares (Excl. Options)
40.41M
Full value: 40,406,555 · shares · 30 Sep 2026Price
$115.23
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- CORT on Nasdaq
- All holders as of 30 Sep 2026
- Q3 2026
- Total 13F shares
- 40,406,555
- Total 13F value
- $4,646,984,138
- Portfolio coverage rank
- 0.01%
- Share change
- -2,122,873
- Value change
- -$223,164,702
- Number of holders
- 311
- Shares outstanding
- 108,024,910
- SEC-reported price per share
- $116.23
- Insider filing price
- $116.23
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- CORT - CORCEPT THERAPEUTICS INC - Common Stock is tracked under CUSIP 218352102.
- 311 institutions reported positions in Q3 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 420 to 311 between Q2 2026 and Q3 2026.
- SEC-reported value moved from to
$7.15B
Full value: $7,146,287,822 · USD · 30 Jun 2026.$4.65B
Full value: $4,646,984,138 · USD · 30 Sep 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 311 institutions filings for Q3 2026.
Security key
218352102
13F reference period
Q3 2026
13F holders
311
13D/G owners
4
CIK / CUSIP context first
Open Q3 2026 holders
CORT full holder history
CORCEPT THERAPEUTICS INC SEC filings
CORCEPT THERAPEUTICS INC company facts
CORCEPT THERAPEUTICS INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 218352102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
CORT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 8.9% | -18% | $1,107,846,225 | -$221,804,153 | 9,614,217 | -17% | BlackRock, Inc. | 30 Sep 2026 |
| INGALLS & SNYDER LLC | 6.8% | -12% | $292,790,314 | -$36,692,379 | 7,263,466 | -11% | INGALLS & SNYDER LLC | 31 Dec 2025 |
| BELANOFF JOSEPH K | 6.3% | $499,599,592 | 6,822,335 | Joseph K. Belanoff | 31 Dec 2024 | |||
| RENAISSANCE TECHNOLOGIES LLC | 4.9% | -11% | $482,017,741 | -$45,521,009 | 5,261,628 | -8.6% | Renaissance Technologies LLC | 01 Apr 2026 |
As of 30 Sep 2026,
311
institutional investors reported holding
shares of
CORCEPT THERAPEUTICS INC - Common Stock (CORT).
This represents
37%
of the company’s total
outstanding shares.
40.41M
Full value: 40,406,555 · shares · 30 Sep 2026108.02M
Full value: 108,024,910 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
33%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| INGALLS & SNYDER LLC | 7.1% | 7,667,798 | -3.4% | 23% | $883,560,000 |
| RENAISSANCE TECHNOLOGIES LLC | 4.5% | 4,850,083 | -7.8% | 0.76% | $558,875,064 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.4% | 4,777,065 | -5.3% | 0.02% | $550,461,200 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 4,353,398 | +4.3% | 0.01% | $501,642,052 |
| STATE STREET CORP | 2.9% | 3,104,960 | -5.3% | 0.01% | $357,784,541 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 2,335,372 | -7.8% | 0.01% | $269,156,621 |
| FIRST TRUST ADVISORS LP | 1.3% | 1,368,324 | -25% | 0.09% | $157,671,960 |
| DIMENSIONAL FUND ADVISORS LP | 0.89% | 964,417 | -27% | 0.02% | $111,127,944 |
| MORGAN STANLEY | 0.87% | 934,790 | -18% | 0.01% | $107,716,111 |
| Cerity Partners LLC | 0.77% | 828,281 | +3.9% | 0.11% | $95,442,821 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 0.7% | 759,176 | +6.9% | 0.26% | $87,479,881 |
| EMERALD ADVISERS, LLC | 0.7% | 758,257 | +1.3% | 2.4% | $87,373,954 |
| VANGUARD FIDUCIARY TRUST CO | 0.57% | 618,242 | +0.68% | 0.02% | $71,240,026 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 0.44% | 473,881 | +1.9% | 2.2% | $54,605,308 |
| Invesco Ltd. | 0.4% | 432,521 | -17% | 0% | $49,839,394 |
| FEDERATED HERMES, INC. | 0.39% | 421,742 | 0.07% | $48,597,331 | |
| Boston Trust Walden Corp | 0.22% | 235,673 | -46% | 0.22% | $27,156,599 |
| FRANKLIN TEMPLETON INC | 0.21% | 223,209 | +5.3% | 0% | $17,682,617 |
| Swiss National Bank | 0.18% | 195,365 | +1.7% | 0.01% | $22,511,909 |
| VAN ECK ASSOCIATES CORP | 0.15% | 157,904 | +13% | 0.01% | $18,195,278 |
| Granite Investment Partners, LLC | 0.13% | 141,986 | -18% | 0.89% | $16,361,047 |
| ROYCE & ASSOCIATES LP | 0.12% | 132,800 | -0.38% | 0.14% | $15,302,544 |
| Mariner, LLC | 0.12% | 130,714 | +45% | 0.02% | $15,062,142 |
| F/m Investments LLC | 0.11% | 116,997 | +33% | 0.4% | $13,481,564 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.1% | 109,605 | -0.85% | 0.01% | $12,629,784 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 40,406,555 | $4,646,984,138 | -$223,164,702 | $115.23 | 311 |
| 2026 Q2 | 82,167,335 | $7,146,287,822 | +$350,649,234 | $86.95 | 420 |
| 2026 Q1 | 79,462,335 | $3,202,329,305 | +$152,685,096 | $40.31 | 350 |
| 2025 Q4 | 76,610,607 | $2,668,599,587 | -$117,770,292 | $34.80 | 384 |
| 2025 Q3 | 77,152,974 | $6,407,786,320 | -$135,227,246 | $83.11 | 424 |
| 2025 Q2 | 78,953,366 | $5,792,808,674 | -$256,092,991 | $73.40 | 418 |
| 2025 Q1 | 81,954,269 | $9,118,688,561 | -$126,808,558 | $114.22 | 408 |
| 2024 Q4 | 84,197,994 | $4,242,065,667 | -$207,314,469 | $50.39 | 362 |
| 2024 Q3 | 88,403,089 | $4,090,692,212 | +$3,394,284 | $46.28 | 316 |
| 2024 Q2 | 89,225,655 | $2,899,048,485 | -$128,567,810 | $32.49 | 282 |
| 2024 Q1 | 93,600,393 | $2,357,405,516 | +$206,853,940 | $25.19 | 283 |
| 2023 Q4 | 84,732,406 | $2,752,093,285 | +$61,774,959 | $32.48 | 269 |
| 2023 Q3 | 83,019,792 | $2,261,938,980 | +$53,168,814 | $27.24 | 244 |
| 2023 Q2 | 81,489,147 | $1,813,024,077 | -$128,901,748 | $22.25 | 224 |
| 2023 Q1 | 87,299,563 | $1,890,881,420 | +$97,037,592 | $21.66 | 231 |
| 2022 Q4 | 83,493,481 | $1,696,055,001 | -$86,283,839 | $20.31 | 241 |
| 2022 Q3 | 87,114,680 | $2,234,275,240 | +$46,310,026 | $25.64 | 225 |
| 2022 Q2 | 85,057,351 | $2,023,773,420 | +$98,901,040 | $23.78 | 214 |
| 2022 Q1 | 81,373,846 | $1,836,938,219 | +$19,570,522 | $22.52 | 214 |
| 2021 Q4 | 80,562,329 | $1,594,701,243 | -$8,205,377 | $19.80 | 199 |
| 2021 Q3 | 80,869,592 | $1,591,453,895 | +$4,936,347 | $19.68 | 193 |
| 2021 Q2 | 80,507,190 | $1,769,402,198 | -$27,080,717 | $22.00 | 193 |
| 2021 Q1 | 81,631,723 | $1,941,273,564 | -$37,899,526 | $23.79 | 205 |
| 2020 Q4 | 83,389,910 | $2,180,799,586 | -$129,685,932 | $26.16 | 219 |
| 2020 Q3 | 89,228,523 | $1,552,636,140 | +$5,152,396 | $17.40 | 215 |